BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18268888)

  • 1. Prevalence of the BCR/ABL1 transcripts in Mexican patients with chronic myelogenous leukemia.
    Meza-Espinoza JP; Gutiérrez-Angulo M; Vázquez-Cárdenas A; Delgado-Lamas JL; Esparza-Flores MA; González-García JR
    Rev Invest Clin; 2007; 59(5):338-41. PubMed ID: 18268888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
    Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia.
    Adler R; Viehmann S; Kuhlisch E; Martiniak Y; Röttgers S; Harbott J; Suttorp M
    Eur J Haematol; 2009 Feb; 82(2):112-8. PubMed ID: 19067742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
    Goh HG; Hwang JY; Kim SH; Lee YH; Kim YL; Kim DW
    Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ
    Rev Invest Clin; 2004; 56(5):605-8. PubMed ID: 15776864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia.
    Todoric-Zivanovic B; Strnad M; Stamatovic D; Tukic L; Krtolica K; Tatomirovic Z; Djordjevic V; Bogdanovic A; Jankovic G; Magic Z
    J BUON; 2011; 16(1):104-7. PubMed ID: 21674858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia].
    Rosas-Cabral A; Martínez-Mancilla M; Ayala-Sánchez M; Vela-Ojeda J; Bahena-Reséndiz P; Vadillo-Buenfil M; Aviña-Zubieta JA; Salazar-Exaire D; Miranda-Peralta E; Marroquín A; Longoria-Revilla E
    Gac Med Mex; 2003; 139(6):553-9. PubMed ID: 14723051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of chronic myeloid leukemia in eastern India.
    Mondal BC; Bandyopadhyay A; Majumdar S; Mukhopadhyay A; Chandra S; Chaudhuri U; Chakrabarti P; Bhattacharyya S; Dasgupta UB
    Am J Hematol; 2006 Nov; 81(11):845-9. PubMed ID: 16888785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic and molecular analysis of 1193 cases with chronic myeloid leukemia].
    Jiang DZ; Chen ZM; Lou JY; Wang YG; Liang Y; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):1-5. PubMed ID: 17649716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate resistance in a chronic myeloid leukemia patient with a novel e8a2 BCR-ABL transcript variant.
    Qin YZ; Jiang B; Jiang Q; Zhang Y; Jiang H; Li JL; Zhu HH; Li LD; Liu YR; Chen SS; Huang XJ
    Acta Haematol; 2008; 120(3):146-9. PubMed ID: 19039205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis.
    Romero-Morelos P; González-Yebra AL; Muñoz-López D; Lara-Lona E; González-Yebra B
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.
    Burmeister T; Reinhardt R
    Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and comparison of clinicohematological parameters and molecular and cytogenetic response of two Bcr/Abl fusion transcripts.
    Polampalli S; Choughule A; Negi N; Shinde S; Baisane C; Amre P; Subramanian PG; Gujral S; Prabhash K; Parikh P
    Genet Mol Res; 2008 Oct; 7(4):1138-49. PubMed ID: 19048492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular detection of the BCR-ABL gen by RT-PCR in Costa Rican children with leukemia].
    Jiménez-Arce G; Carrillo J; Chaves M; Jiménez R; Vargas M; Campos L; de la Guardia A; Valverde B
    Rev Biol Trop; 2008 Dec; 56(4):1613-8. PubMed ID: 19419069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.
    Qin YZ; Liu YR; Zhu HH; Li JL; Ruan GR; Zhang Y; Jiang Q; Jiang H; Li LD; Chang Y; Huang XJ; Chen SS
    Int J Lab Hematol; 2008 Aug; 30(4):317-23. PubMed ID: 18665830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.